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hazard models were then constructed for time to stroke and atrial fibrillation 
(AF) diagnoses through 2010. Hazard ratios (HR) were computed for each value of 
the predictor variable. RESULTS: Among patients with one risk factor, age 75+ 
was most strongly associated with the occurrence of both stroke and AF (HR 6.87 
and 9.16, respectively), followed by HF (HR 4.48 and 4.70). Hypertension (HR 2.06 
and 2.64) and diabetes (HR 2.03 and 1.82), along with age, were the risk factors 
with the highest prevalence. For patients age 75+, the additional presence of 
HTN or diabetes conferred nearly additive risk for stroke or AF (HR 9.64 and 14.83 
with HTN; 9.93 and 11.64 with diabetes). In contrast, the combination of age 75+ 
and HF on the risk of AF was supra-additive (HR 28.63). CONCLUSIONS: 
Previously established, common risk factors were found to be strongly associated 
with the subsequent occurrence of stroke and AF in a claims database. 
Additionally, the proposed methodology, combined with the large sample size of 
a claims database, provided valuable and easily interpretable insights on the 
levels of interactions among risk factors. Similar methodology may prove useful 
for establishing important risk combinations and interactions in the treatment 
and prevention of other conditions.  
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OBJECTIVES: To evaluate the potential economic implications of alternative 
treatment strategies for acute bacterial skin and skin structure infections 
(ABSSSIs) by capturing the impact of the initial empiric antibiotic selection, 
switches to 2nd line antibiotics, course length, route of administration and 
location of care. METHODS: The treatment pathway of each patient is simulated 
through various locations (emergency department (ED), inpatient, and 
outpatient). Patients responding at 72 hours may transfer to the outpatient 
setting to complete the course, switch antibiotic at discharge or receive 2nd line 
treatment due to lack of response or relapse. Analysis of US inpatient claims 
(Premier Hospital Database) provided length of stay information. Results from 
three scenarios are presented - each cohort was assigned to 1st line vancomycin 
(VAN). At discharge, one cohort completed the VAN course, one switched to oral 
linezolid (LIN) and the other to daptomycin (DAP). Costs (2012 USD from the 
Medicare perspective) and time in each location are accrued throughout the 
entire treatment course. RESULTS: Compared to VAN (10.1), hospital plus 
outpatient days were greater with LIN (13.4) and DAP (10.8), but total costs were 
reduced by $2,465 and $252 with LIN and DAP respectively, suggesting avoiding 
repeated outpatient infusion center visits lowers costs. Outpatient care 
comprises 32% (LIN) to 50% (VAN) of total costs and will remain important to 
consider as treatment pathways move further towards the outpatient setting. 
CONCLUSIONS: The choice of antibiotic and location of care have a substantial 
impact on resource use and costs. The economic implications of new treatment 
options currently in development such as long-acting lipoglycopeptide IV 
antibiotics (oritavancin and dalbavancin), which avoid repeated infusions and 
are anticipated to allow providers to shift more care to the ambulatory setting, 
can be assessed using the modeling framework presented here.  
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OBJECTIVES: To compared model fit and impact on key treatment effect 
estimates from incorporating the assumption of drug class effects in MTCs. 
METHODS: Two MTC data sets on early and advanced Parkinson’s disease (PD) 
comprising of several pharmacotherapies belonging to one of the three drug 
classes: dopamine receptor agonists (DOAs), monoamine-oxidase B inhibitors 
(MOAB-I), and adenosine A2 antagonists (A2A). We used three models: 1) a 
conventional random-effects MTC assuming all drugs were independent (model 
1); 2) an MTC assuming all drug belonging to the same class exhibited equal 
effects (model 2); and 3) an MTC assuming some overall drug class effect for each 
drug class, but allowing for each drug to differ from their class’ overall effect 
(model 3). We analysed the effect of the included interventions (and drug 
classes) on improvement on the Unified Parkinson’s Disease Rating Scale 
(UPDRS) part II and III. We compared model fits (DIC) and the impact on 
treatment effects and 95% credible intervals from using these three models. 
RESULTS: For the early PD data set, the model 3 yielded the smallest DIC. 
Treatment effects from all models were similar, but 95% credible intervals were 
generally narrower with model 3 and generally the widest with model 1. For the 
advanced PD data set, model 2 yielded a slightly smaller DIC than model 3, and 
both smaller DIC than model 1. However, all treatment effects and 95% credible 
intervals were highly similar. CONCLUSIONS: Incorporating the drug class effect 
assumption in MTCs may provider better model fits, and thus, more reliable 
estimates of comparative efficacy and safety.  
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OBJECTIVES: To quantify preferences for allocating hypothetical time savings in 
cystic fibrosis (CF) inhaled antibiotic treatment among health care and non-
health care activities. METHODS: Adult patients with a self-reported physician 
diagnosis of CF and parents of juvenile CF patients in the United States who have 
Pseudomonas aeruginosa in their culture at least twice a year completed a web-
enabled, discrete-choice experiment survey. Respondents evaluated treatment-
choice and routine-choice alternatives followed by stated adherence for 
themselves and other people. Questions required evaluating pairs of 
hypothetical inhalation devices and routine profiles defined by inhalation device 
features, side effects, time spent on inhaled antibiotic treatment, time spent on 
hypertonic saline, time spent on other CF-care activities, and lung function 
measured as forced expiratory volume in one second (FEV1). Respondents also 
answered a question indicating how they would allocate 80 hypothetical minutes 
of time savings per day among CF-care and non-CF-care activities (work, sleep, 
family activities, and social activities). Using a conceptual framework describing 
optimal time allocations within a health production function, random-
parameters logit models were used to quantify trade-off preferences among 
efficacy, treatment-time adherence, and competing time demands. RESULTS: 
The final sample included 174 adult patients and 130 parents. On average, adult 
patients would spend 9% of the time saved on additional CF-care activities and 
the remaining time would be almost evenly split between work, social activities, 
and sleep. Juvenile patients would spend 11% of the time saved on additional CF-
care activities and about 2.5 times more minutes in social activities than in work 
and 2 times more minutes in social activities than in sleep. CONCLUSIONS: 
Some of the time saved on taking inhaled antibiotics would be reallocated to 
activities with treatment benefits such as exercise and taking hypertonic saline 
as well as activities such as sleep that may improve health outcomes.  
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OBJECTIVES: Generic preference-based measures like EQ-5D and SF-6D have 
been criticised for being narrowly focused on sub-set of health dimensions. One 
potential solution to this problem is to use the increasingly promoted subjective 
well-being approach, which considers the overall impact on a person’s well-
being and is based on experiences rather than hypothetical preferences. The aim 
of this study is to explore whether EQ-5D is adequate in reflecting the impact of 
long-standing health conditions on life satisfaction. METHODS: Using data from 
a UK general population cohort health (N = 13,591) collected between 2010 and 
2012 on EQ-5D, long-standing health conditions (self-reported), and life 
satisafaction using a response scale from 1 (completely dissatisfied) to 6 
(completely satisfied), this study employs ordered and generalised logit 
regression models. The impact of EQ-5D and long-standing health conditions on 
life satisfaction is assessed by examining the coefficients on dummy variables. 
RESULTS: The EQ-5D alone has coefficients that suggest anxiety/depression has 
the largest impact on life satisfaction (odds ratios ranging from 0.65 to 0.26). Self-
care has less impact (0.78) and pain/discomfort has the least (0.91). The long-
standing health conditions alone have coefficients that suggest insomnia has the 
largest impact on life satisfaction (0.71). The EQ-5D and long-standing health 
conditions have coefficients that suggest insomnia have a strong impact on life 
satisfaction (0.86) in the ordered logit model. Diabetes has a stronger impact on 
life satisfaction (0.72) in the generalised logit model. The largest difference in 
coefficients between the models is observed for severe anxiety/depression (odd 
ratio dropped significantly from 0.60 to 0.26). CONCLUSIONS: This study provides 
evidence of statistically significant differences between the models, and the 
comparison of the coefficients suggests inclusion of the bolt-on extra 
dimensions for EQ-5D could affect life satisfaction. Therefore, diabetes and 
insomnia could be newly discovered bolt-on dimensions for EQ-5D.  
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OBJECTIVES: To compare the effect of using PTC or MTC on the results of cost-
effectiveness analysis of pharmacotherapies for chronic obstructive pulmonary 
disease (COPD). METHODS: A discrete-time Markov model was developed to 
reflect the cost and effectiveness of five COPD commonly used interventions 
including inhaled corticosteroids (ICS), long-acting beta agonists (LABA), 
ICS+LABA, long-acting muscarinic agents (LAMA), and no treatment (placebo). 
We pooled rate ratios (RR) of preventing COPD exacerbations using both Bayesian 
PTC and Bayesian MTC methods. We compared the impact of PTC versus MTC on 
the outcomes of the expected value of information (EVI) analysis. RESULTS: The 
expected value of perfect information (EVPI) values at willingness-to-pay of 
$50,000/QALY for all permutations of comparisons were calculated and 
compared between PTC and MTC analyses. The EVPI when all 5 treatments are 
compared is $1,281.1 for PTC and $557.3 for MTC analyses. When the future trial 
is planned to have only two intervention arms, among all ten possible 
permutations, the RCT that compares Placebo versus ICS+LABA had the highest 
EVPI when evidence was synthesized using MTC; on the other hand the RCT that 
compares LABA versus ICS+LABA had the highest EVPI using PTC analysis. 
Similarly, for RCTs with three and four arms, the strategy with highest EVPI 
changed across MTC and PTC analyses. CONCLUSIONS: The evidence generated 
using the entire network of comparisons resulted in substantial changes in the 
